Synthesis of 2´-hydroxy-4´-isoprenyloxychalcone derivatives with potential antidepressant-like activity. 2014

Chao Xie, and Zhou Peng, and Shui-Lian Zhao, and Cheng-Yan Pan, and Li-Ping Guan, and Xian-Yu Sun

A series of 2´-hydroxy-4´-isoprenyloxychalcone derivatives was synthesized and evaluated for its antidepressant- like activity using the FST and TST. All compounds exhibited the potential antidepressant-like activity in the FST and the TST through intraperitoneal injection. Among them, compounds 4i, 4l and 4n exhibited more potent antidepressant- like activity at a dose of 10 mg/kg. And, compounds 4i, 4l and 4n were also adequately absorbed in mice after oral administration at a dose of 30 mg/kg. In the 5-HT induced head-twitch test and yohimbine induced mortality test, compound 4i could increase the head-twitch and rise mortality in mice. The results suggested that the antidepressant effects of compound 4i may be related to via the serotonergic and noradrenergic system.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D005106 Exploratory Behavior The tendency to explore or investigate a novel environment. It is considered a motivation not clearly distinguishable from curiosity. Curiosity,Novelty-Seeking Behavior,Behavior, Exploratory,Behavior, Novelty-Seeking,Behaviors, Exploratory,Behaviors, Novelty-Seeking,Curiosities,Exploratory Behaviors,Novelty Seeking Behavior,Novelty-Seeking Behaviors
D006916 5-Hydroxytryptophan The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant. 5-HTP,Hydroxytryptophan,Oxitriptan,Oxytryptophan,Tryptophan, 5-Hydroxy-,5 Hydroxytryptophan,5-Hydroxy- Tryptophan,Tryptophan, 5 Hydroxy
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D013315 Stress, Psychological Stress wherein emotional factors predominate. Cumulative Stress, Psychological,Emotional Stress,Individual Stressors,Life Stress,Psychological Cumulative Stress,Psychological Stress Experience,Psychological Stress Overload,Psychologically Stressful Conditions,Stress Experience, Psychological,Stress Measurement, Psychological,Stress Overload, Psychological,Stress Processes, Psychological,Stress, Emotional,Stressful Conditions, Psychological,Psychological Stress,Stress, Psychologic,Stressor, Psychological,Condition, Psychological Stressful,Condition, Psychologically Stressful,Conditions, Psychologically Stressful,Cumulative Stresses, Psychological,Experience, Psychological Stress,Individual Stressor,Life Stresses,Measurement, Psychological Stress,Overload, Psychological Stress,Psychologic Stress,Psychological Cumulative Stresses,Psychological Stress Experiences,Psychological Stress Measurement,Psychological Stress Measurements,Psychological Stress Overloads,Psychological Stress Processe,Psychological Stress Processes,Psychological Stresses,Psychological Stressful Condition,Psychological Stressful Conditions,Psychological Stressor,Psychological Stressors,Psychologically Stressful Condition,Stress Experiences, Psychological,Stress Processe, Psychological,Stress, Life,Stress, Psychological Cumulative,Stressful Condition, Psychological,Stressful Condition, Psychologically,Stressor, Individual

Related Publications

Chao Xie, and Zhou Peng, and Shui-Lian Zhao, and Cheng-Yan Pan, and Li-Ping Guan, and Xian-Yu Sun
January 1999, Acta poloniae pharmaceutica,
Chao Xie, and Zhou Peng, and Shui-Lian Zhao, and Cheng-Yan Pan, and Li-Ping Guan, and Xian-Yu Sun
May 2000, European journal of medicinal chemistry,
Chao Xie, and Zhou Peng, and Shui-Lian Zhao, and Cheng-Yan Pan, and Li-Ping Guan, and Xian-Yu Sun
September 2020, Antibiotics (Basel, Switzerland),
Chao Xie, and Zhou Peng, and Shui-Lian Zhao, and Cheng-Yan Pan, and Li-Ping Guan, and Xian-Yu Sun
March 2015, Chemical biology & drug design,
Chao Xie, and Zhou Peng, and Shui-Lian Zhao, and Cheng-Yan Pan, and Li-Ping Guan, and Xian-Yu Sun
July 1970, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Chao Xie, and Zhou Peng, and Shui-Lian Zhao, and Cheng-Yan Pan, and Li-Ping Guan, and Xian-Yu Sun
June 2016, Chemical biology & drug design,
Chao Xie, and Zhou Peng, and Shui-Lian Zhao, and Cheng-Yan Pan, and Li-Ping Guan, and Xian-Yu Sun
October 2000, Archiv der Pharmazie,
Chao Xie, and Zhou Peng, and Shui-Lian Zhao, and Cheng-Yan Pan, and Li-Ping Guan, and Xian-Yu Sun
December 1972, Journal of medicinal chemistry,
Chao Xie, and Zhou Peng, and Shui-Lian Zhao, and Cheng-Yan Pan, and Li-Ping Guan, and Xian-Yu Sun
February 1994, Farmaco (Societa chimica italiana : 1989),
Chao Xie, and Zhou Peng, and Shui-Lian Zhao, and Cheng-Yan Pan, and Li-Ping Guan, and Xian-Yu Sun
January 1994, Acta poloniae pharmaceutica,
Copied contents to your clipboard!